ALEJANDRO PEPEN ROMERO
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology FREEPORT, NY NPI 1619257003
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NY Bayer HealthCare Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$525.28
- Category: General Payments
- Program years: PY2018–2022
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $174.59 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.59 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $48.56 | 2 |
| Horizon Pharma plc | $44.79 | 2 |
| Amgen Inc. | $42.77 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $25.06 | 1 |
| Acerta Pharma LLC | $13.41 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 915064951 | AstraZeneca Pharmaceuticals LP | $13.41 | 07/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 927062373 | CALLIDITAS THERAPEUTICS US INC. | $25.06 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 929990411 | Bayer HealthCare Pharmaceuticals Inc. | $19.68 | 02/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 930112705 | Bayer HealthCare Pharmaceuticals Inc. | $28.88 | 02/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 937673589 | Horizon Therapeutics plc | $16.00 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 937673591 | Horizon Therapeutics plc | $28.79 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 939879443 | Amgen Inc. | $22.21 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 939879445 | Amgen Inc. | $20.56 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.